- EGFR Signaling Pathway
- TGF-beta Signaling
- Canonical Wnt Signaling
- non-Canonical Wnt Signaling
- Notch Signaling
- p53 Pathway
- NF-kB Pathway
- Cytokine Signaling
>Mouse MAb Antibody
>Influenza B Hemagglutinin / HA Antibody, Mouse MAb
|Catalog||Size (Price)||Quantity||In Stock||Operation|
Influenza B Virus HA / Hemagglutinin Antibody
|Order or Inquire for Influenza B HA Antibody product||Quality antibodies||Antibody production services|
|Detection limit is 12.5 ng/lane in WB|
Influenza B Virus HA / Hemagglutinin Antibody Product Information
Recombinant Influenza B virus HA protein ( Catalog#11053-V08H )
|Antibody Type :||Mouse Monoclonal Antibody ( Mouse mAb Service Platform )|
Clone ID :
|Ig Type :||
|Formulation :||0.2 μm filtered solution in PBS, 5% trehalose may be added in some batches. Please read the hardcopy of COA or contact our customer service to confirm the formulation.|
This antibody was produced from a hybridoma resulting from the fusion of a mouse myeloma with B cells obtained from a mouse immunized with purified, human cell-derived, recombinant influenza B virus HA ( rvHA ; Catalog#11053-V08H ; ACA33493.1 ; Met 1 - Ala 555 ). The IgG fraction of the cell culture supernatant was purified by Protein A affinity chromatography.
Influenza B Virus HA / Hemagglutinin Antibody Usage Guide
Influenza B ( B/Florida/04/06 ) HA
|No cross-reactivity in ELISA with
H1N1 (A/Brisbane/59/2007) HA
H2N2 (A/Canada/720/2005) HA
H3N2 (A/Brisbane/10/2007) HA
H4N4 (A/mallard/Ohio/657/2002) HA
H5N1 (A/Anhui/1/2005) HA
H5N8 (A/northern shoveler/California/HKWF115/2007) HA
H7N7 (A/Netherlands/219/03) HA
H8N4 (A/pintail duck/Alberta/114/1979) HA
H9N2 (A/Hong Kong/1073/99) HA
H10N3 (A/duck/Hong Kong/786/1979) HA
H11N2 (A/duck/Yangzhou/906/2002) HA
H12N5 (A/green-winged teal/ALB/199/1991) HA
H13N8 (A/black-headed gull/Netherlands/1/00) HA
H15N8 (A/duck/AUS/341/1983) HA
H16N3 (A/black-headed gull/Sweden/5/99) HA
|Western blot :||This antibody can be used at 1 - 2 μg/mL with the appropriate secondary reagents to detect influenza B virus HA in WB. Using a DAB detection system, the detection limit for influenza B virus HA is approximately 12.5 ng/lane under non-reducing conditions and reducing conditions|
|Storage :||This antibody can be stored at 2℃-8℃ for one month without detectable loss of activity. Antibody products are stable for twelve months from date of receipt when stored at -20℃ to -70℃. Preservative-Free.
Sodium azide is recommended to avoid contamination (final concentration 0.05%-0.1%). It is toxic to cells and should be disposed of properly. Avoid repeated freeze-thaw cycles.
Related Influenza Virus Research Tools
Influenza B Virus HA / Hemagglutinin Antibody Background
Influenza (flu) is a respiratory infection in mammals and birds. This virus is divided into three main types (A, B and C). Influenza A is found in a wide variety of bird and mammal species. Influenza B is largely confined to humans and is an important cause of morbidity. Influenza C infects humans, dogs and pigs, sometimes causing both severe illness and local epidemics. Influenza A is further divided into subtypes based on differences in the membrane proteins hemagglutinin (HA) and neuraminidase (NA). The notation HhNn is used to refer to the subtype comprising the hth discovered HA protein and the nth discovered NA protein. The HA is a trimer with a receptor binding pocket on the globular head of each monomer. Subtypes are further divided into strains. Each genetically distinct virus isolate is usually considered to be a separate strain. Influenza B viruses are only known to infect humans and seals, giving them influenza. This limited host range is apparently responsible for the lack of Influenza virus B caused influenza pandemics in contrast with those caused by the morphologically similar Influenza virus A as both mutate by both genetic drift and reassortment. Influenza B viruses evolve slower than A viruses and faster than C viruses. Influenza B virus mutates at a rate 2 to 3 times lower than type A. However, influenza B mutates enough that lasting immunity is not possible.
- Hay AJ, et al., 2001, Philos. Trans. R. Soc. Lond., B, Biol. Sci. 356 (1416): 1861-70.
- Li KS, et al., 2004, Nature. 430: 209-13.
- Matsuzaki Y, et al., 2004, J. Med. Virol. 74 (1): 132-40.
- Taubenberger JK, et al., 2008. Annu Rev Pathol. 3: 499-522.
- Christophe F, et al., 2009, Science. 324:1557-1561.
- Guan Y, et al., 2009, Revue scientifique et technique. 23 (2): 453-65.
Browse by Product Type
|Protein :||hemagglutinin (HA), neuraminidase (NA), nucleoprotein (NP), matrix protein 1 (M1), nonstructural protein 1 (NS1), nonstructural protein 2 (NS2), influenza antigen (influenza protein)|
|ELISA Kit :||Influenza ELISA Kit|
|Gene :||Influenza Gene / Influenza cDNA Clone|
Browse by Subtype